Tobacco Use Disorder
📧 Sign up to get email alerts when something new happens for Tobacco Use Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2011-03-24Clinical Trial Update: Direct to Smoker Outreach in a Health Care Setting [NA]
A completed clinical trial conducted at Massachusetts General Hospital evaluating direct-to-smoker outreach in a health care setting for tob…
-
CLINICAL_TRIALS trial_result · 2011-03-14Clinical Trial Update: Bupropion SR for Treating Smokeless Tobacco Use [Phase 3]
A Phase 3 trial evaluating sustained-release bupropion for treating smokeless tobacco use has completed.
-
CLINICAL_TRIALS research · 2011-03-02Clinical Trial Update: Evaluation of a Combined Parent-student Programme for Smoking Prevention in Berlin Schools [NA]
This entry provides an update on a Charite University clinical trial evaluating a combined parent–student smoking-prevention program in Berl…
-
CLINICAL_TRIALS trial_result · 2011-02-23Clinical Trial Update: PET Imaging Study on Occupancy of Dopamine D2 Receptors and Genotypes After Bupropion Administration [Phase 4]
This completed Phase 4 PET imaging trial investigated dopamine D2 receptor occupancy and genotype in smokers after administration of bupropi…
-
CLINICAL_TRIALS trial_result · 2011-02-11Clinical Trial Update: Timing of Smoking Intervention in Alcohol Treatment (Nicotine Patch) [Phase 4]
Phase 4 trial update evaluating the timing of a nicotine patch smoking cessation intervention during alcohol treatment. The study status is …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2010-12-23Clinical Trial Update: Chantix & Bupropion for Smoking Cessation [Phase 3]
Phase 3 trial comparing Chantix (varenicline) with bupropion for smoking cessation has completed. Results were posted in 2010.
-
CLINICAL_TRIALS trial_result · 2010-12-10Clinical Trial Update: Comparison of Efficacy and Safety of Rimonabant 5mg/Day or 20mg/Day Versus Placebo in Smoking Cessation [Phase 3]
This Phase 3 clinical trial update compares rimonabant at 5 mg/day and 20 mg/day with placebo for smoking cessation. The study status is com…
-
CLINICAL_TRIALS trial_result · 2010-12-10Clinical Trial Update: Comparison of the Efficacy and Safety of 2 Oral Doses of Rimonabant, 5 mg/Day or 20 mg/Day, Versus Placebo, as an Aid to Smoking Cessation (STRATUS US) [Phase 3]
A Phase 3 trial comparing two daily doses of rimonabant (5 mg and 20 mg) to placebo for smoking cessation has completed. The STRATUS US stud…
-
CLINICAL_TRIALS trial_result · 2010-11-30Clinical Trial Update: Varenicline For Smokers In Recovery From Alcohol Dependence [Phase 2, Phase 3]
Clinical trial update for varenicline in individuals recovering from alcohol dependence, evaluating tobacco abstinence outcomes in Phase 2 a…
-
CLINICAL_TRIALS trial_result · 2010-11-22Clinical Trial Update: Intervention for Support Persons to Help Smokers Quit [Phase 1, Phase 2]
Phase 1/Phase 2 clinical trial evaluating an intervention for support persons to help smokers quit. The study status is completed.
-
CLINICAL_TRIALS trial_result · 2010-11-02Clinical Trial Update: Comparison of Standard Versus Extended Nicotine Patch Therapy for Smoking Cessation [Phase 3]
Phase 3 clinical trial comparing standard versus extended nicotine patch therapy for smoking cessation; results were posted in 2010.
-
CLINICAL_TRIALS trial_result · 2010-09-30Clinical Trial Update: Randomized Study Comparing the Efficacy and Safety of Varenicline Tartrate to Placebo in Smoking Cessation When Subjects Are Allowed to Set Their Own Quit Date [Phase 4]
A Phase 4 randomized trial comparing varenicline tartrate with placebo for smoking cessation in participants allowed to set their own quit d…
-
CLINICAL_TRIALS trial_result · 2010-09-29Clinical Trial Update: Behavioral Counseling for Alcohol Dependent Smokers (Nicotine Patch) [Phase 4]
Phase 4 trial evaluating behavioral counseling for alcohol use disorder patients who smoke, using a nicotine patch.
-
CLINICAL_TRIALS trial_result · 2010-09-15Clinical Trial Update: Combined Nortriptyline and Transdermal Nicotine for Smoking Cessation [Phase 2]
Phase 2 trial evaluating combined nortriptyline and a transdermal nicotine patch for smoking cessation; the study has completed.
-
CLINICAL_TRIALS trial_result · 2010-08-09Clinical Trial Update: Assessing Neuropsychiatric Symptoms Including Depression, Anxiety, Irritability, and Suicidal Thoughts or Behavior in Subjects Quitting Smoking on Varenicline Tartrate or Placebo [Phase 4]
Phase 4 randomized trial assessing neuropsychiatric symptoms (depression, anxiety, irritability, and suicidal thoughts or behavior) in adult…
-
CLINICAL_TRIALS trial_result · 2010-07-27Clinical Trial Update: Safety and Efficacy of the Novel Selective Nicotinic Receptor Partial Agonist, CHANTIX (Varenicline) in Patients With Acute Coronary Syndrome [Phase 4]
An ongoing Phase 4 trial assessing the safety and efficacy of varenicline (CHANTIX) for smoking cessation in patients with acute coronary sy…
-
CLINICAL_TRIALS trial_result · 2010-07-23Clinical Trial Update: Exercise, Smoking Cessation and Adolescents [Phase 1, Phase 2]
An ongoing Phase 1/2 trial from Temple University investigates exercise and smoking cessation in adolescents; current status is unknown.
-
CLINICAL_TRIALS research · 2010-07-20Clinical Trial Update: Yoga for Women Attempting Smoking Cessation [Phase 3]
This document is an update on a Phase 3 clinical trial evaluating yoga for women attempting smoking cessation, sponsored by The Miriam Hospi…
-
CLINICAL_TRIALS trial_result · 2010-07-12Clinical Trial Update: Smoking Cessation Program: A Quality Improvement Trial in a Resident-Based Outpatient Clinic
This is a terminated quality improvement clinical trial in a resident outpatient clinic evaluating a smoking cessation program.
-
CLINICAL_TRIALS trial_result · 2010-07-08Clinical Trial Update: Single-dose Nicotine Pharmacokinetics With a New Oral Nicotine Replacement Product [NA]
A completed McNeil AB trial evaluated the pharmacokinetics of a single oral dose of a new nicotine replacement product for tobacco dependenc…
-
CLINICAL_TRIALS trial_result · 2010-07-05Clinical Trial Update: Study of Bronchial Inflammation in Adolescent Smokers With and Without Obesity
A completed clinical trial assessing bronchial inflammation in adolescent smokers with and without obesity.
-
FDA approval · 2010-06-25FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for Bupropion Hydrochloride from Actavis Pharma, Inc., bringing this generic product under the appro…
-
FDA approval · 2010-06-17FDA Approved: GOOD NEIGHBOR PHARMACY NICOTINE — Supplemental Application (Amerisource Bergen)
FDA approved a supplemental application for GOOD NEIGHBOR PHARMACY NICOTINE (NICOTINE POLACRILEX) submitted by Amerisource Bergen.
-
FDA approval · 2010-06-17FDA Approved: NICOTINE — Supplemental Application (H E B)
FDA approved a supplemental application for nicotine polacrilex (nicotine) submitted by H E B, expanding the approved product under an exist…
-
FDA approval · 2010-06-17FDA Approved: FOSTER AND THRIVE NICOTINE — Supplemental Application (Strategic Sourcing Services LLC)
FDA lists a supplemental application for Foster and Thrive Nicotine (nicotine polacrilex) from Strategic Sourcing Services LLC, with the sub…